Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
The market for temporary mechanical circulatory support devices has shown substantial growth recently, driven by evolving medical needs and technological progress. This sector is poised for continued expansion as innovations improve patient outcomes and broaden applications. Below is a detailed exploration of the market size, growth drivers, key players, and regional trends shaping the future of this critical medical device industry.
Temporary Mechanical Circulatory Support Device Market Size and Growth Projections
The temporary mechanical circulatory support device market has experienced notable growth over recent years and is expected to continue this trajectory. Market revenue is projected to climb from $2.66 billion in 2025 to $2.9 billion in 2026, reflecting a compound annual growth rate (CAGR) of 9.0%. This early growth phase was driven by factors such as limited availability of these devices, dependence on invasive open-heart surgeries, high mortality rates associated with cardiogenic shock, increasing demand for acute cardiac care, and a shortage of portable or wearable alternatives. Looking ahead, the market is anticipated to reach $4.1 billion by 2030, maintaining the same CAGR of 9.0%, thanks to advancements in biomimetic and hybrid technologies, greater adoption of minimally invasive devices, rising volumes of cardiac surgeries, growth of outpatient cardiac centers, and integration of digital monitoring systems and smart hemodynamic management.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27434&type=smp
Factors Fueling Market Expansion in Temporary Mechanical Circulatory Support Devices
A key driver behind the market’s growth is the rising prevalence of cardiovascular diseases worldwide. These conditions, which include heart attacks, strokes, and hypertension, predominantly affect aging populations, who are more susceptible to heart and blood vessel disorders. Temporary mechanical circulatory support devices play an essential role in managing these diseases by offering short-term support to compromised heart function and improving blood circulation during critical events such as heart failure or cardiogenic shock. As an example, a December 2024 report from GOV.UK showed that in March 2024 nearly 2.24 million adults in England—about 4.4% of those aged 18 and older—had a recorded diagnosis of chronic kidney disease, an increase from the previous year, highlighting the rising burden of related cardiovascular complications.
Additional Growth Drivers Encouraging Revenue Potential
Technological innovation is also a significant growth catalyst for the temporary mechanical circulatory support device market. The development of biomimetic and hybrid devices, which mimic natural heart functions more closely, along with the rise in minimally invasive procedures, is expanding the range of treatable patients and improving recovery outcomes. Furthermore, the expansion of outpatient cardiac centers and the integration of smart digital monitoring tools allow for enhanced management of patient hemodynamics, making these devices more efficient and user-friendly. These advancements contribute to growing adoption rates and open new revenue streams for manufacturers.
Access The Complete Temporary Mechanical Circulatory Support Device Market Report:
Product and Segment Breakdown in the Temporary Mechanical Circulatory Support Device Market
This market is segmented across multiple dimensions to address various clinical needs:
– By Type: Left Ventricular Support Devices, Right Ventricular Support Devices, and Biventricular Support Devices
– By Technology: Pneumatic Devices, Mechanical Pumps, Biomimetic Devices, Hybrid Systems, and Novel Wearable Devices
– By Application: Cardiogenic Shock, Bridge to Transplant, Bridge to Recovery, High-Risk Cardiac Procedures, and Others
– By End User: Hospitals, Cardiac Surgery Centers, Outpatient Surgical Facilities, Research and Academic Institutions, and Other Users
Further subcategories delve into specific device types, such as Intra-Aortic Balloon Pumps, Percutaneous Ventricular Assist Devices, Extracorporeal Membrane Oxygenation (ECMO) systems, Right Ventricular Assist Devices, Temporary Total Artificial Hearts, and more, reflecting the diversity and specialization within the market.
Innovations and Partnerships Spurring Market Development
Leading companies are actively pursuing partnerships and investments to accelerate innovation in temporary mechanical circulatory support devices. For example, in November 2025, VenstraMedical, an Australian cardiovascular device firm, teamed up with Highcroft Capital, a US venture capital firm, to secure funding aimed at advancing their next-generation percutaneous ventricular assist device (pVAD). This catheter-based pump is designed to provide full ventricular unloading and hemodynamic support for patients experiencing cardiogenic shock or undergoing high-risk coronary interventions. Patented technologies enable minimally invasive insertion, with the device capable of delivering up to 7 liters of cardiac output per minute. This collaboration reflects a strong commitment to revolutionizing tMCS technology in a market valued at over $2 billion, with clinical trials and commercialization on the horizon.
Key Industry Players Influencing Market Direction
Several prominent companies dominate the temporary mechanical circulatory support device industry, including Abbott Laboratories, Medtronic Plc, Boston Scientific Corporation, Terumo Corporation, Getinge AB, LivaNova PLC, Magenta Medical Ltd., CorWave SA, Procyrion Inc., CardioBridge GmbH, Abiomed Inc., Berlin Heart GmbH, Thoratec Corporation, PulseCath BV, TandemLife Inc., SynCardia Systems LLC, CardiacAssist Inc., Xenios AG, Nihon Kohden Corporation, Eurosets Srl, Senko Medical Instrument Manufacturing Co Ltd, Nipro Medical Corporation, Calon Cardio-Technology Ltd., and Windmill Cardiovascular Systems Inc. These companies are instrumental in advancing product innovation, expanding market reach, and setting industry standards.
Regional Market Overview and Expansion Drivers
In terms of geography, North America held the largest share of the temporary mechanical circulatory support device market in 2025. However, the Asia-Pacific region is anticipated to experience the fastest growth during the forecast period due to factors such as increasing healthcare infrastructure investments, rising cardiovascular disease prevalence, and growing awareness of advanced treatment options. The market report covers additional regions including South East Asia, Western Europe, Eastern Europe, South America, the Middle East, and Africa, providing a comprehensive perspective on global market dynamics and regional opportunities.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
